Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
7.89
-0.43 (-5.17%)
May 14, 2025, 11:32 AM - Market open
Intellia Therapeutics Employees
Intellia Therapeutics had 403 employees as of December 31, 2024. The number of employees decreased by 123 or -23.38% compared to the previous year.
Employees
403
Change (1Y)
-123
Growth (1Y)
-23.38%
Revenue / Employee
$113,074
Profits / Employee
-$1,304,998
Market Cap
817.27M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
NTLA News
- 2 days ago - Intellia Therapeutics Shares Have Struggled, But It's Now Go-Time (Rating Upgrade) - Seeking Alpha
- 5 days ago - Intellia Therapeutics, Inc. (NTLA) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 9 days ago - CRISPR Therapeutics And Intellia Therapeutics: Balancing Market Uncertainty Against Pipeline Catalysts - Seeking Alpha
- 13 days ago - Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2025 Earnings and Company Updates - GlobeNewsWire
- 21 days ago - Lawsuit for Investors in shares of Intellia Therapeutics, Inc. (NASDAQ: NTLA) announced by the Shareholders Foundation - PRNewsWire
- 4 weeks ago - Final Deadline Today for the Intellia Therapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - NTLA - PRNewsWire
- 4 weeks ago - SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Intellia Therapeutics - PRNewsWire